Biomea Fusion

BMEA45

$7.09arrow_drop_down11.42%-$0.91

BMEA45

$7.09

arrow_drop_down11.42%-$0.91

Performance History

Key Stats
Open	$8.02
Prev. Close	$8.03
EPS	-4.01
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	7.92	8.24
52 Week Range	3.61	22.74

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-4.01

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Biomea Fusion (BMEA)

Biomea Fusion, Inc., commonly known as BMEA, is a biopharmaceutical company specializing in the development of targeted therapies for cancer. With a focus on precision medicine, Biomea Fusion aims to deliver innovative treatments that address the underlying genetic drivers of various cancer types. The company's mission is to improve patient outcomes and quality of life through the advancement of personalized oncology therapies.

As of the latest market data, the stock price of Biomea Fusion, Inc. (BMEA) has shown significant growth over time. Investors have witnessed positive trends in the value of BMEA shares, reflecting the market's confidence in the company's potential. It is important to consider that stock prices are subject to market fluctuations and other external factors.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Thomas Andrew Butler
Headquarters: Redwood City
Employees: 94
Exchange: NASDAQ

Keep an eye on Biomea Fusion

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Biomea Fusion's (BMEA) price per share?

The current price per share for Biomea Fusion (BMEA) is $7.09. The stock has seen a price change of -$0.92 recently, indicating a -11.42% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Biomea Fusion (BMEA)?

For Biomea Fusion (BMEA), the 52-week high is $22.74, which is 220.51% from the current price. The 52-week low is $3.61, the current price is 96.54% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Biomea Fusion (BMEA) a growth stock?

Biomea Fusion (BMEA) has shown an average price growth of -3.13% over the past three years. It has received a score of 31 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Biomea Fusion as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Biomea Fusion (BMEA) stock price performance year to date (YTD)?

As of the latest data, Biomea Fusion (BMEA) has a year-to-date price change of -51.64%. Over the past month, the stock has experienced a price change of -31.84%. Over the last three months, the change has been 24.26%. Over the past six months, the figure is -38.03%.

help

Is Biomea Fusion (BMEA) a profitable company?

Biomea Fusion (BMEA) has a net income of -$117.26M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$126.14M. Furthermore, the EBITDA is -$149.62M.

help

What is the market capitalization of Biomea Fusion (BMEA)?

Biomea Fusion (BMEA) has a market capitalization of $290.27M. The average daily trading volume is 7.44, indicating the stock's liquidity and investor engagement.